Caliper, Seegene partner to co-market diagnostic tools

By Michelle Lang

MIT’s needleless injection draws interest from Sanofi [May 25, 2012]

Dynasil partners with Mayo Clinic on two projects [May 24, 2012]

Alere recalls 800,000 heart tests, stock drops [May 23, 2012]

Tobii helps users to control computers with their eyes [May 22, 2012]

Caliper Life Sciences Inc. has partnered with Seegene Inc. to combine the two companies’ respective technologies in developing molecular diagnostic products. No financial terms of the partnership were disclosed.

Hopkinton-based Caliper develops the LabChip Dx platform, which has diagnostic identification, scoring and reporting software.

Seegene, a molecular diagnostics firm based in South Korea, develops SeePlex multiplex diagnostic assays.

The two companies said in a news release that they plan to co-market the Caliper LabChip Dx platform and Seegene’s line of diagnostic assays.

Last month, Caliper (Nasdaq: CALP) said it would pay $20 million to acquire Cambridge Research & Instrumentation Inc. (CRi), a developer of optical imaging systems.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.